REAL-WORLD CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH METASTATIC DUCTAL ADENOCARCINOMA (MPDAC) TREATED WITH LIPOSOMAL IRINOTECAN-BASED REGIMENS BY RACE

被引：0
|
作者：
Kim, G. P. [1 ]
Cockrum, P. [2 ]
Lamarre, N. [3 ]
Surinach, A. [3 ]
机构：
[1] George Washington Univ, Washington, DC USA
[2] Ipsen, Cambridge, MA USA
[3] Genesis Res, Hoboken, NJ USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN27
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [41] Real-world clinical outcomes and economic burden of metastatic pancreatic ductal adenocarcinoma: a systematic review
    Cockrum, Paul
    Dennen, Syvart
    Brown, Audrey
    Briggs, Jonathon
    Paluri, Ravi
    FUTURE ONCOLOGY, 2025, 21 (02) : 241 - 260
  • [42] De-escalation and dose density in real-world patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who received FOLFIRINOX in the first line.
    Dennen, Syvart
    Shao, Anran
    Dennen, Syvart
    Cockrum, Paul
    Paluri, Ravi Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 628 - 628
  • [43] Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens
    Ng, Kimmie
    Tabernero, Josep
    Hwang, Jimmy
    Bajetta, Emilio
    Sharma, Sunil
    Del Prete, Salvatore A.
    Arrowsmith, Edward R.
    Ryan, David P.
    Sedova, Michaela
    Jin, Jin
    Malek, Kamel
    Fuchs, Charles S.
    CLINICAL CANCER RESEARCH, 2013, 19 (14) : 3987 - 3995
  • [44] The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens
    M. J. Lamas
    G. Duran
    E. Balboa
    B. Bernardez
    S. Candamio
    Y. Vidal
    A. Mosquera
    J. M. Giraldez
    R. Lopez
    A. Carracedo
    F. Barros
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1591 - 1599
  • [45] Real-world safety and medication use of second-line (2L) 5-fluorouracil (5-FU)-based regimens among patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC).
    Kim, George P.
    Cockrum, Paul
    Surinach, Andy
    Wang, Shu
    Wainberg, Zev A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] The Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma A Single-Center Real-World Study
    Chiang, Cho-Han
    Chiang, Cho-Hung
    Chiang, Cho-Hsien
    Chiu, Jing-Huey
    Ma, Kevin Sheng-Kai
    Chen, Brian Shiian
    Luan, Yu-Ze
    Cheng, Teng-Chieh
    Hsieh, Ching-Lung
    Peng, Cheng-Ming
    PANCREAS, 2022, 51 (08) : E107 - E109
  • [47] Real-world study of treatment patterns and outcomes among patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in Europe.
    Taieb, Julien
    Hammel, Pascal
    Reni, Michele
    Palmer, Daniel H.
    Bridgewater, John A.
    Cubillo, Antonio
    Prager, Gerald W.
    Vermeire, Alice
    D'Esquermes, Nathalie
    Biville-Hedouin, Fabienne
    Teng Zhaoyang
    Seufferlein, Thomas
    Macarulla, Teresa
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [48] Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group
    Yoo, Changhoon
    Im, Hyeon-Su
    Kim, Kyu-pyo
    Oh, Do-Youn
    Lee, Kyung-Hun
    Chon, Hong Jae
    Kim, Joo Hoon
    Kang, Myoungjoo
    Kim, Ilhwan
    Lee, Guk Jin
    Oh, Sung Yong
    Choi, Younak
    Choi, Hye Jin
    Kim, Seung Tae
    Park, Joon Oh
    Ryoo, Baek-Yeol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [49] Real-world outcomes in patients with advanced or metastatic gastric adenocarcinoma in the United States
    Beachler, D.
    Lamy, F.
    Kolitsopoulos, F.
    Dinh, J.
    Papazian, A.
    Jamal-Allial, A.
    Verpillat, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S103 - S103
  • [50] The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma
    Chiang, Nai-Jung
    Shan, Yan-Shen
    Li, Chung-Pin
    Yang, Shih-Hung
    Su, Yung-Yeh
    Chiu, Sz-Chi
    Bai, Li-Yuan
    Chuang, Shih-Chang
    Chan, De-Chuan
    Yen, Chia-Jui
    Peng, Cheng-Ming
    Chiu, Tai-Jan
    Chen, Yen-Yang
    Chen, Jen-Shi
    Chou, Wen-Chi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5062 - 5073
12345